BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22781783)

  • 1. Formononetin reverses established osteopenia in adult ovariectomized rats.
    Tyagi AM; Srivastava K; Singh AK; Kumar A; Changkija B; Pandey R; Lahiri S; Nagar GK; Yadav DK; Maurya R; Trivedi R; Singh D
    Menopause; 2012 Aug; 19(8):856-63. PubMed ID: 22781783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction.
    Pandey R; Gautam AK; Bhargavan B; Trivedi R; Swarnkar G; Nagar GK; Yadav DK; Kumar M; Rawat P; Manickavasagam L; Kumar A; Maurya R; Goel A; Jain GK; Chattopadhyay N; Singh D
    Menopause; 2010; 17(3):602-10. PubMed ID: 20395887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoformononetin, a methoxydaidzein present in medicinal plants, reverses bone loss in osteopenic rats and exerts bone anabolic action by preventing osteoblast apoptosis.
    Srivastava K; Tyagi AM; Khan K; Dixit M; Lahiri S; Kumar A; Changkija B; Khan MP; Nagar GK; Yadav DK; Maurya R; Singh SP; Jain GK; Wahajuddin ; Trivedi R; Chattopadhyay N; Singh D
    Phytomedicine; 2013 Apr; 20(6):470-80. PubMed ID: 23395215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V; Birchman R; Wu DD; Lindsay R
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
    Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ; Bu SY; Wang Y; Rendina E; Lim YF; Marlow D; Clarke SL; Cullen DM; Lucas EA
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel flavonoid, 6-C-beta-d-glucopyranosyl-(2S,3S)-(+)-3',4',5,7-tetrahydroxyflavanone, isolated from Ulmus wallichiana Planchon mitigates ovariectomy-induced osteoporosis in rats.
    Sharan K; Swarnkar G; Siddiqui JA; Kumar A; Rawat P; Kumar M; Nagar GK; Manickavasagam L; Singh SP; Mishra G; Wahajuddin ; Jain GK; Maurya R; Chattopadhyay N
    Menopause; 2010; 17(3):577-86. PubMed ID: 20393370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
    Rissanen JP; Suominen MI; Peng Z; Morko J; Rasi S; Risteli J; Halleen JM
    Calcif Tissue Int; 2008 Feb; 82(2):155-61. PubMed ID: 18219436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new vitamin D analog, 2MD, restores trabecular and cortical bone mass and strength in ovariectomized rats with established osteopenia.
    Ke HZ; Qi H; Crawford DT; Simmons HA; Xu G; Li M; Plum L; Clagett-Dame M; DeLuca HF; Thompson DD; Brown TA
    J Bone Miner Res; 2005 Oct; 20(10):1742-55. PubMed ID: 16160732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A standardized phytopreparation from an Indian medicinal plant (Dalbergia sissoo) has antiresorptive and bone-forming effects on a postmenopausal osteoporosis model of rat.
    Khedgikar V; Gautam J; Kushwaha P; Kumar A; Nagar GK; Dixit P; Chillara R; Voruganti S; Singh SP; Uddin W; Jain GK; Singh D; Maurya R; Chattopadhyay N; Trivedi R
    Menopause; 2012 Dec; 19(12):1336-46. PubMed ID: 22850441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extract and fraction from Ulmus wallichiana Planchon promote peak bone achievement and have a nonestrogenic osteoprotective effect.
    Sharan K; Siddiqui JA; Swarnkar G; Tyagi AM; Kumar A; Rawat P; Kumar M; Nagar GK; Arya KR; Manickavasagam L; Jain GK; Maurya R; Chattopadhyay N
    Menopause; 2010 Mar; 17(2):393-402. PubMed ID: 20009959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methoxyisoflavones formononetin and isoformononetin inhibit the differentiation of Th17 cells and B-cell lymphopoesis to promote osteogenesis in estrogen-deficient bone loss conditions.
    Mansoori MN; Tyagi AM; Shukla P; Srivastava K; Dev K; Chillara R; Maurya R; Singh D
    Menopause; 2016 May; 23(5):565-76. PubMed ID: 27070807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ; Ratkus AM; Thomsen JS; Vulcan Q; Mosekilde L
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
    Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
    Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonprostanoid EP4 receptor selective prostaglandin E2 agonist restores bone mass and strength in aged, ovariectomized rats.
    Ke HZ; Crawford DT; Qi H; Simmons HA; Owen TA; Paralkar VM; Li M; Lu B; Grasser WA; Cameron KO; Lefker BA; DaSilva-Jardine P; Scott DO; Zhang Q; Tian XY; Jee WS; Brown TA; Thompson DD
    J Bone Miner Res; 2006 Apr; 21(4):565-75. PubMed ID: 16598377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats.
    Ma X; Meng J; Jia M; Bi L; Zhou Y; Wang Y; Hu J; He G; Luo X
    J Bone Miner Res; 2013 Jul; 28(7):1641-52. PubMed ID: 23427056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption.
    Varela A; Chouinard L; Lesage E; Smith SY; Hattersley G
    J Bone Miner Res; 2017 Jan; 32(1):24-33. PubMed ID: 27748532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomized rats.
    Ominsky MS; Li X; Asuncion FJ; Barrero M; Warmington KS; Dwyer D; Stolina M; Geng Z; Grisanti M; Tan HL; Corbin T; McCabe J; Simonet WS; Ke HZ; Kostenuik PJ
    J Bone Miner Res; 2008 May; 23(5):672-82. PubMed ID: 18433301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE; Thompson JM; Strewler GJ; Kinney JH
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.